Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Garnero

Showing results (21-30 of 119) with videos related to

Pageof 12
Sort By:
Clinical Laboratory|February 17, 2009
Bone markers--new aspectsSerge Cremers, John P Bilezikian, Patrick Garnero
Bone|November 19, 2003
Serum leptin as a determinant of bone resorption in healthy postmenopausal womenChristian Roux, Asma Arabi, Raphaël Porcher, et al.
Annals of the Rheumatic Diseases|January 6, 2007
Effect of chondroitin sulphate in symptomatic knee osteoarthritis: a multicentre, randomised, double-blind, placebo-controlled studyBernard Mazières, Michel Hucher, Mohammed Zaïm, et al.
Calcified Tissue International|May 10, 2012
Cathepsin K preferentially solubilizes matured bone matrixOlivier Borel, Evelyne Gineyts, Cindy Bertholon, et al.
Maturitas|June 23, 2004
The effect of continuous oestradiol with intermittent norgestimate on bone mineral density and bone turnover in post-menopausal womenStefan Arrenbrecht, Patrick Caubel, Patrick Garnero, et al.
The Journal of Rheumatology|October 10, 2008
Circulating dickkopf-1 and radiological progression in patients with early rheumatoid arthritis treated with etanerceptPatrick Garnero, Nadine Charni-Ben Tabassi, Nathalie Voorzanger-Rousselot
Arthritis and Rheumatism|December 30, 2009
Rapid and sustained improvement in bone and cartilage turnover markers with the anti-interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: results from a substudy of the multicenter double-blind, placebo-controlled trial of tocilizumab in inadequate responders to methotrexate alonePatrick Garnero, Elizabeth Thompson, Thasia Woodworth, et al.
Bone|February 22, 2012
Reference intervals of bone turnover markers in healthy premenopausal women: results from a cross-sectional European studyRichard Eastell, Patrick Garnero, Christine Audebert, et al.
Bone|December 17, 2008
Bone turnover and type I collagen C-telopeptide isomerization in adult osteogenesis imperfecta: associations with collagen gene mutationsPatrick Garnero, Anne-Marie Schott, Darwin Prockop, et al.
Bone|December 17, 2009
Increased cartilage type II collagen degradation in patients with osteogenesis imperfecta used as a human model of bone type I collagen alterationsJean-Charles Rousseau, Guillaume Chevrel, Anne-Marie Schott, et al.
Pageof 12

Showing results (21-30 of 119) with videos related to

Sort By:
Pageof 12
Clinical Laboratory|February 17, 2009
Bone markers--new aspectsSerge Cremers, John P Bilezikian, Patrick Garnero
Bone|November 19, 2003
Serum leptin as a determinant of bone resorption in healthy postmenopausal womenChristian Roux, Asma Arabi, Raphaël Porcher, et al.
Annals of the Rheumatic Diseases|January 6, 2007
Effect of chondroitin sulphate in symptomatic knee osteoarthritis: a multicentre, randomised, double-blind, placebo-controlled studyBernard Mazières, Michel Hucher, Mohammed Zaïm, et al.
Calcified Tissue International|May 10, 2012
Cathepsin K preferentially solubilizes matured bone matrixOlivier Borel, Evelyne Gineyts, Cindy Bertholon, et al.
Maturitas|June 23, 2004
The effect of continuous oestradiol with intermittent norgestimate on bone mineral density and bone turnover in post-menopausal womenStefan Arrenbrecht, Patrick Caubel, Patrick Garnero, et al.
The Journal of Rheumatology|October 10, 2008
Circulating dickkopf-1 and radiological progression in patients with early rheumatoid arthritis treated with etanerceptPatrick Garnero, Nadine Charni-Ben Tabassi, Nathalie Voorzanger-Rousselot
Arthritis and Rheumatism|December 30, 2009
Rapid and sustained improvement in bone and cartilage turnover markers with the anti-interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: results from a substudy of the multicenter double-blind, placebo-controlled trial of tocilizumab in inadequate responders to methotrexate alonePatrick Garnero, Elizabeth Thompson, Thasia Woodworth, et al.
Bone|February 22, 2012
Reference intervals of bone turnover markers in healthy premenopausal women: results from a cross-sectional European studyRichard Eastell, Patrick Garnero, Christine Audebert, et al.
Bone|December 17, 2008
Bone turnover and type I collagen C-telopeptide isomerization in adult osteogenesis imperfecta: associations with collagen gene mutationsPatrick Garnero, Anne-Marie Schott, Darwin Prockop, et al.
Bone|December 17, 2009
Increased cartilage type II collagen degradation in patients with osteogenesis imperfecta used as a human model of bone type I collagen alterationsJean-Charles Rousseau, Guillaume Chevrel, Anne-Marie Schott, et al.
Pageof 12